Saturna Capital continued to hold its stake in shares of AstraZeneca plc (NYSE:AZN) during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,000 shares of the biopharmaceutical company’s stock at the end of the third quarter. Saturna Capital’s holdings in AstraZeneca plc were worth […]
